Fingerprint
Dive into the research topics of 'Gefitinib versus placebo in completely resected non-small-cell lung cancer: Results of the NCIC CTG BR19 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gefitinib versus placebo in completely resected non-small-cell lung cancer: Results of the NCIC CTG BR19 study
Glenwood D. Goss, Chris O'Callaghan, Ian Lorimer, Ming Sound Tsao, Gregory A. Masters, James Jett, Martin J. Edelman, Rogerio Lilenbaum, Hak Choy, Fadlo Khuri, Katherine Pisters, David Gandara, Kemp Kernstine, Charles Butts, Jonathan Noble, Thomas A. Hensing, Kendrith Rowland, Joan Schiller, Keyue Ding, Frances A. Shepherd
Research output: Contribution to journal › Article › peer-review
292
Scopus
citations